Zusätzlich wurden 22 Hybrid-DRG-Fälle erbracht: L17N 6 L20M 7 L20N 9
Services search (in the department)
| Illness | Number of cases |
|---|---|
| Obstructive uropathy and refluxuropathy - Hydronephrosis in obstruction by renal and ureteral calculi - Hydronephrosis in obstruction by ureteral calculi (N13.21) | 26 |
| Malignant neoplasm of bladder - Malignant neoplasm of overlapping sites of bladder (C67.8) | 25 |
| Hyperplasia of prostate (N40) | 21 |
| Malignant neoplasm of bladder - Malignant neoplasm of lateral wall of bladder (C67.2) | 12 |
| Malignant neoplasm of bladder - Malignant neoplasm of posterior wall of bladder (C67.4) | 10 |
| Obstructive and reflux uropathy - Obstructive and reflux uropathy unspecified (N13.9) | 7 |
| Unspecified haematuria (R31) | 6 |
| Malignant neoplasm of prostate (C61) | 4 |
| Obstructive uropathy and refluxuropathy - Hydronephrosis in obstruction by renal and ureteral stone - Hydronephrosis in obstruction by renal and ureteral stone stone location unspecified (N13.29) | 4 |
| Calculus of kidney and ureter - Calculus of kidney (N20.0) | 4 |
| Treatment | Number |
|---|---|
| (5-98k.0) | 72 |
| Surgical incision, removal or destruction of diseased tissue in the urinary bladder, with access through the urethra (5-573.40) | 56 |
| Insertion, exchange or removal of a ureteral stent (8-137.00) | 39 |
| X-rays of the kidney and urinary tract with contrast medium (3-13d.5) | 36 |
| Insertion, exchange or removal of a ureteral stent (8-137.10) | 32 |
| Computed tomography (CT) of the abdomen without contrast medium (3-207) | 24 |
| Injection or administration of medicines into the urinary bladder (8-132.3) | 15 |
| Dilatation of the ureters during an operation or endoscopy (5-560.2) | 14 |
| Surgical removal or destruction of prostatic tissue through the urethra (5-601.0) | 12 |
| Surgical removal or destruction of prostatic tissue through the urethra (5-601.1) | 12 |
Department key: 2200
Inpatient department
| Bezeichnung | |
| Teilnahme externe Qualitätssicherung | 0 |
| Bezeichnung | |
| Teilnahme externe Qualitätssicherung | 0 |
| Bezeichnung | |
| Teilnahme externe Qualitätssicherung | 0 |
| No. | Explanation |
|---|---|
| CQ31 |
| Number | Group |
|---|---|
| 33 | Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training* |
| 28 | Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence |
| 28 | Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations |
| Job | Explanation |
|---|---|
| Lectureships / teaching posts at colleges and universities | |
| Student training (clinical traineeship / internship year) |
| No. | Training in other healing professions | Comment |
|---|---|---|
| HB19 | Nursing professionals | |
| HB17 | Auxiliary nurse (m/f) | |
| HB15 | Anaesthesia technical assistant (m/f) | |
| HB07 | Surgical technical assistant (m/f) |
Thorsten Sleifir
Klinikgeschäftsführer
Phone:
07631
-88-4006
Mail:
ed.tiehdnuseg-soileh@rifiels.netsroht
Dr. med. Sascha Al Agha
Ärztlicher Direktor
Phone:
07631
-88-1122
Mail:
ed.tiehdnuseg-soileh@ahgAlA.ahcsaS
Dr. med. Sascha Al Agha
Vorsitzender der Hygienekommission, Ärztlicher Direktor
Phone:
07631
-88-1122
Mail:
ed.tiehdnuseg-soileh@ahgAlA.ahcsaS